FDA Adverse Event Injury Summary report: N

ADAPTER SLEEVES 12/14 +2

MDR report key: 3022778 · Received March 27, 2013

Report

Report Number
1818910-2013-04344
Event Type
Injury
Date Received
March 27, 2013
Date of Event
March 18, 2013
Report Date
August 2, 2013
Manufacturer
DEPUY INTERNATIONAL
Product Code
KWA
PMA / PMN Number
PK040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS COMPLAINT CLOSED.

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Description of Event or Problem · 1

PATIENT WAS REVISED DUE TO PAIN, SLIGHT MILKY FLUID CAM FROM JOINT AND SIGNS OF FRETTING ON THE SLEEVE AND TAPER WERE NOTED INTEROPERATIVE.

Description of Event or Problem · 1

**UPDATE** (B)(4) 2013 - PLAINTIFF¿S PRELIMINARY DISCLOSURE FORM WAS RECEIVED, WHICH IDENTIFIED PART/LOT INFORMATION. THE COMPLAINT AND ASSOCIATED MDRS WERE UPDATED. THERE WAS NO NEW INFORMATION THAT WOULD CHANGE THE OUTCOME OF THE INVESTIGATION.

Description of Event or Problem · 1

**UPDATE**(B)(4) 2013 - LITIGATION RECEIVED ALLEGING THAT THE PATIENT SUFFERS FROM EXCESSIVE LEVELS OF CHROMIUM AND COBALT. THE DOI WAS PROVIDED. THERE IS NO NEW ADDITIONAL INFORMATION THAT WOULD AFFECT THE OUTCOME OF THE INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
126655 ADAPTER SLEEVES 12/14 +2 TOTAL HIP IMPLANT KWA DEPUY INTERNATIONAL 2160174

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention